Semler Scientific Inc. (SMLR): Price and Financial Metrics
GET POWR RATINGS... FREE!
SMLR POWR Grades
- SMLR scores best on the Quality dimension, with a Quality rank ahead of 99.3% of US stocks.
- SMLR's strongest trending metric is Quality; it's been moving up over the last 178 days.
- SMLR's current lowest rank is in the Momentum metric (where it is better than 10.48% of US stocks).
SMLR Stock Summary
- For SMLR, its debt to operating expenses ratio is greater than that reported by only 0.52% of US equities we're observing.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.13 for SEMLER SCIENTIFIC INC; that's greater than it is for just 10.53% of US stocks.
- As for revenue growth, note that SMLR's revenue has grown 1.63% over the past 12 months; that beats the revenue growth of 27.37% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to SEMLER SCIENTIFIC INC are NVST, NSYS, NTIC, DCGO, and SIG.
- Visit SMLR's SEC page to see the company's official filings. To visit the company's web site, go to www.semlerscientific.com.
SMLR Valuation Summary
- SMLR's price/sales ratio is 4; this is 100% higher than that of the median Healthcare stock.
- SMLR's price/sales ratio has moved down 10.2 over the prior 107 months.
Below are key valuation metrics over time for SMLR.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SMLR | 2022-12-02 | 4.0 | 4.1 | 17.1 | 11.0 |
| SMLR | 2022-12-01 | 3.9 | 4.1 | 16.9 | 10.9 |
| SMLR | 2022-11-30 | 3.7 | 3.9 | 16.1 | 10.2 |
| SMLR | 2022-11-29 | 3.6 | 3.8 | 15.7 | 9.9 |
| SMLR | 2022-11-28 | 3.6 | 3.8 | 15.6 | 9.8 |
| SMLR | 2022-11-25 | 3.8 | 4.0 | 16.6 | 10.6 |
SMLR Growth Metrics
- The 5 year net income to common stockholders growth rate now stands at 722.71%.
- The year over year net cashflow from operations growth rate now stands at -20.45%.
- Its 4 year revenue growth rate is now at 376.67%.
The table below shows SMLR's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 54.433 | 17.41 | 12.616 |
| 2022-06-30 | 54.377 | 17.026 | 13.091 |
| 2022-03-31 | 53.86 | 12.952 | 15.705 |
| 2021-12-31 | 53.027 | 16.056 | 17.222 |
| 2021-09-30 | 53.558 | 20.216 | 21.108 |
| 2021-06-30 | 50.294 | 16.097 | 21.824 |
SMLR's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SMLR has a Quality Grade of A, ranking ahead of 95.98% of graded US stocks.
- SMLR's asset turnover comes in at 1.347 -- ranking 8th of 186 Medical Equipment stocks.
- FONR, ATRI, and STXS are the stocks whose asset turnover ratios are most correlated with SMLR.
The table below shows SMLR's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.347 | 0.913 | 2.860 |
| 2021-03-31 | 1.358 | 0.904 | 2.919 |
| 2020-12-31 | 1.489 | 0.913 | 3.050 |
| 2020-09-30 | 1.634 | 0.908 | 2.764 |
| 2020-06-30 | 1.732 | 0.899 | 2.244 |
| 2020-03-31 | 2.128 | 0.898 | 2.802 |
SMLR Price Target
For more insight on analysts targets of SMLR, see our SMLR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $94.67 | Average Broker Recommendation | 1.33 (Strong Buy) |
SMLR Stock Price Chart Interactive Chart >
SMLR Price/Volume Stats
| Current price | $30.86 | 52-week high | $99.99 |
| Prev. close | $31.59 | 52-week low | $26.70 |
| Day low | $30.86 | Volume | 1,906 |
| Day high | $31.43 | Avg. volume | 57,800 |
| 50-day MA | $35.73 | Dividend yield | N/A |
| 200-day MA | $38.90 | Market Cap | 211.08M |
Semler Scientific Inc. (SMLR) Company Bio
Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform to evaluate patients with various chronic diseases. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers. It offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is based in San Jose, California.
Latest SMLR News From Around the Web
Below are the latest news stories about SEMLER SCIENTIFIC INC that investors may wish to consider to help them evaluate SMLR as an investment opportunity.
Semler Reports Third Quarter and Year-to-Date 2022 Financial ResultsSemler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2022. |
Semler to Report Third Quarter and First Nine Months of 2022 Financial Results and Host Conference Call on November 1, 2022Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2022, after the close of U.S. financial markets on Tuesday, November 1, 2022. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Wei |
Semler Scientific to Present at Upcoming Investor ConferencesSemler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced, Head of Corporate Communications and Business Strategy, Renae Cormier, will participate in the following investor conferences: |
Are Investors Undervaluing Semler Scientific, Inc. (NASDAQ:SMLR) By 49%?How far off is Semler Scientific, Inc. ( NASDAQ:SMLR ) from its intrinsic value? Using the most recent financial data... |
Semler Reports Second Quarter and First Half of 2022 Financial ResultsSemler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2022. |
SMLR Price Returns
| 1-mo | 5.98% |
| 3-mo | -32.18% |
| 6-mo | -0.32% |
| 1-year | -67.15% |
| 3-year | -28.40% |
| 5-year | 298.19% |
| YTD | -66.33% |
| 2021 | -2.50% |
| 2020 | 95.83% |
| 2019 | 39.53% |
| 2018 | 330.00% |
| 2017 | 451.72% |
Continue Researching SMLR
Want to do more research on Semler Scientific Inc's stock and its price? Try the links below:Semler Scientific Inc (SMLR) Stock Price | Nasdaq
Semler Scientific Inc (SMLR) Stock Quote, History and News - Yahoo Finance
Semler Scientific Inc (SMLR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...